Dr. Reddy's Labs - RDY Net earnings per share (EPS TTM)

Dr. Reddy's Laboratories (RDY) is actively diversifying its active ingredient delivery channels to ensure stable exports. The business is capitalizing on vacant niches in sanctioned markets while overcoming currency fluctuations and logistical chaos. Sustained demand for generics guarantees a reliable cash flow. The rolling profit per unit history clearly demonstrates this trend, where 0.36 determines the current status of the parameter.
Analytical breakdowns for Dr. Reddy's Laboratories

This indicator reflects the actual balance of supply and demand by calculating annual net profit, excluding one-off factors and the impact of the total number of shares. By analyzing the 12-month EPS trend chart, an investor can see the capitalization efficiency, which at Dr. Reddy's Laboratories (RDY) is supported by the robotization of production lines and packaging automation, minimizing manual labor costs.